Olema Pharmaceuticals, Inc. Common Stock (OLMA) Stock Price
OLMAStock
$10.91+81.08%52W
Market Cap$954.60M
P/E—
PEG Ratio—
Div yield—
Beta1.98
OLMA Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-64.70%
Price vs S&P 500 (4W)-13.29%
VGM Score43.94
OLMA Earnings Surprise History
Q2 25-0.51est. -0.44
Q3 25-0.49est. -0.47
Q4 25-0.50est. -0.53
Q1 26-0.52est. -0.54
Q2 26-0.61est. -0.56
OLMA Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.26
4.26
4.22
4.22
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OLMAOlema Pharmaceuticals, Inc. Common Stock | — | — | C | $10.91 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Olema Pharmaceuticals, Inc. Common Stock
Olema Pharmaceuticals is a clinical-stage biopharmaceutical company focused on targeted therapies for women's cancers. Its pipeline includes OP-1250, which has completed preclinical studies, and OP-3136. The company aims to improve outcomes for women living with cancer.